Full name
GOODWILL PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
70.21.Z - Head office activities and management consultancy
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 96,6 | 160,1 | 565 | 252,8 |
Profit (loss) on sale | -42,9 | -31,2 | -114,6 | -267,1 |
Gross profit (loss) | -43,2 | -63,7 | -343,9 | -440,3 |
Net profit (loss) | -43,2 | -63,7 | -343,9 | -440,3 |
Cash | 15,8 | 29,4 | 117,7 | 301,1 |
Liabilities and provisions for liabilities | 94,8 | 222 | 970,7 | 337,3 |
Net income from sale | 15,6 | 26,7 | 423,3 | 1484 |
Short time liabilities | 94,8 | 175 | 663,7 | 279,3 |
Other operating costs | 0 | 31,8 | 205,1 | 545,3 |
Working assets | 96,6 | 160,1 | 565 | 252,8 |
Equity capital | 1,8 | -61,8 | -405,8 | -556,1 |
Other income costs | 0 | 0 | 1 | 66 846,7 |
Operating profit (EBIT) | -42,9 | -63 | -318,7 | -405,9 |
% | % | % | p.p. | |
Profitability of capital | -2383,4 | 102,9 | 84,8 | -18,1 |
Equity capital to total assets | 1,9 | -38,6 | -71,8 | -33,2 |
Gross profit margin | -276,1 | -238,2 | -81,3 | 156,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2212 | 2390 | 572 | -1818 |
Current financial liquidity indicator | 1.0191184282302856 | 0.9151615500450134 | 0.8511846661567688 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane